Summary
In 56 patients leucocyte and differential counts were done before and at weekly intervals during PUVA treatment of chronic recalcitrant psoriasis. A statistical significant (P<0.01) decrease in the percentage of neutrophils was observed during the first week of the PUVA therapy. This observation could be closely related to the clinical clearing of psoriasis (P=0.02).
The effect of PUVA therapy in psoriasis may be due to a decrease in the number of immunocompetent neutrophils demonstrated in psoriatic lesions.
Zusammenfassung
56 Patienten mit chronischer behandlungsresistenter Psoriasis wurden mit PUVA behandelt. Unmittelbar vor Behandlungsanfang und danach einmal wöchentlich wurde eine qualitative und quantitative Bestimmung des weißen Blutbildes vorgenommen.
Die Konzentration neutrophiler Granulocyten fiel während der ersten Behandlungswoche signifikant (P<0,01) und korrelierte wohl mit den klinischen Behandlungseffekt (P=0,02).
Der Effekt der PUVA Behandlung beruht möglicherweise auf einer Reduktion der Anzahl immunokompetenter neutrophiler Granulocyten in den Psoriasis-Plaques.
Similar content being viewed by others
References
Cormane, R. H., Hunyadi, J., Hamerlinck, F.: The role of lymphoid cells and polymorphonuclear leukocytes in the pathogenesis of psoriasis. Proc. Sec. Int. Symp. pp. 48–49. Farber et al. (eds.). New York: Yorke Medical Books 1976
Everett, M. A., Yeargers, E., Sayre, R. M., Olson, R. L.: Penetration of epidermis by ultraviolet rays. Photochem. Photobiol. 5, 533–542 (1966)
Haematologi, Aa.Videbaek, (ed). p. 134, 3rd ed. Copenhagen: Munksgård 1970
Ippen, H.: Topical agents for protection against ultraviolet radiation. In: Biological effects of ultraviolet radiation. pp. 681–687. F. Urbach (ed.). New York: Pergamon Press 1969
Krogh, H. K.: The significance of stratum corneum antibodies: An experimental model in guinea pigs. Proc. Sec. Int. Symp., p. 55. Farber et al. (eds.). New York: Yorke Medical Books 1976
Kraemer, K. H., Weinstein, G. D.: Decreased thymidine incorporation in circulating leukocytes after treatment of psoriasis with psoralen and long-wave ultraviolet light. J. invest. Derm. 69, 211–214 (1977)
Lever, W. F.: Histopathology of the skin. p. 137, 5th ed. Toronto: J. B. Lippincott Co., 1975
Melski, J. W., Tanenbaum, L., Parrish, J. A., Fitzpatrick, T. B., Bleich, H. L.: Oral methoxsalen photochemotherapy for the treatment of psoriasis: A cooperative clinical trial. J. invest. Derm. 68, 328–335 (1977)
Musajo, L., Rodighiero, G.: Photoreactions of furocouramins with nucleic acids. VI. Int. Congr. Photobiol. Bochum, W. Germany 1972
Nyfors, A., Rothenborg, H. W.: Cutaneous blood flow in psoriasis measured by 133 Xenon clearance. J. invest. Derm. 54, 381–385 (1970)
Parrish, J. A., Fitzpatrick, T. B., Tanenbaum, L., Pathak, M. A.: Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. New Engl. J. Med. 291, 1207–1210 (1974)
Pathak, M. A., Ebstein, J. H.: Disorders due to physical agents. In: Dermatology in general medicine, p. 995. T. B. Fitzpatrick et al. (eds.). New York: McGraw-Hill 1971
Pathak, M. A., Riley, F. C., Fitzpatrick, T. B.: Melanogenesis in human skin following exposure to long-wave ultraviolet and visible light. J. invest. Derm. 39, 435–443 (1962)
Walter, J. F., Voorhees, J. J., Kelsey, W. H., Duell, E. A., Arbor, A.: Psoralen plus black light inhibits epidermal DNA synthesis. Arch. Derm. 107, 861–865 (1973)
Wolff, K., Fitzpatrick, T. B., Parrish, M. A., Tanenbaum, L.: Photochemotherapy for psoriasis with orally administered methoxsalen. Arch. Derm. 112, 943–949 (1976)
Wolff, K., Hönigsmann, H., Gschnait, F., Konrad, K.: Photochemotherapie bei psoriasis. Dtsch. med. Wschr. 48, 2471–2477 (1975)
Zaynoun, S., Konrad, K., Gschnait, F., Wolff, K.: The pigmentary response to photochemotherapy. Acta derm.-venereol. (Stockh.) 57, 431–440 (1977)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dahl, K.B., Nyfors, A. & Brodthagen, H. Decrease in neutrophils observed in vivo in psoriatics after PUVA therapy. Arch Dermatol Res 262, 131–134 (1978). https://doi.org/10.1007/BF00455580
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00455580